Effects of synthetic and natural lysophosphatidic acids on the arterial blood pressure of different animal species - PubMed (original) (raw)

• PMID: 703535
• DOI: 10.1007/BF02533598

Effects of synthetic and natural lysophosphatidic acids on the arterial blood pressure of different animal species

A Tokumura et al. Lipids. 1978 Aug.

Abstract

Intravenous injection of lysophosphatidic acid was found to cause hypertension in rats and guinea pigs, but hypotension in cats and rabbits. The potencies of the pressor and depressor effects of synthetic lysophosphatidic acids in rats and cats depended on their chain length and the degree of unsaturation of their fatty acyl moieties.

PubMed Disclaimer

Similar articles

• Effects of lysophosphatidic acids and their structural analogs on arterial blood pressure of cats.
  Tokumura A, Maruyama T, Fukuzawa K, Tsukatani H. Tokumura A, et al. Arzneimittelforschung. 1985;35(3):287-92. Arzneimittelforschung. 1985. PMID: 3846454
• Stimulatory effect of lysophosphatidic acids on uterine smooth muscles of non-pregant rats.
  Tokumura A, Fukuzawa K, Yamada S, Tsukatani H. Tokumura A, et al. Arch Int Pharmacodyn Ther. 1980 May;245(1):74-83. Arch Int Pharmacodyn Ther. 1980. PMID: 6902643
• [Cyclic phosphatidic acids and their analogues--unique lipid mediators].
  Grzelczyk A, Koziołkiewicz M. Grzelczyk A, et al. Postepy Biochem. 2012;58(3):327-43. Postepy Biochem. 2012. PMID: 23373418 Review. Polish.

Cited by

• Lysophosphatidic acid causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells.
  Chen C, Ochoa LN, Kagan A, Chai H, Liang Z, Lin PH, Yao Q. Chen C, et al. Atherosclerosis. 2012 May;222(1):74-83. doi: 10.1016/j.atherosclerosis.2012.02.010. Epub 2012 Feb 13. Atherosclerosis. 2012. PMID: 22424734 Free PMC article.
• A rapid phospholipase A2 bioassay using 14C-oleate-labelled E. coli bacterias.
  Meyer T, von Wichert P, Weins D. Meyer T, et al. Klin Wochenschr. 1989 Feb 1;67(3):113-8. doi: 10.1007/BF01711334. Klin Wochenschr. 1989. PMID: 2648055
• Expression of lysophosphatidic acid receptors in the human lower esophageal sphincter.
  Feng Y, Liu JF. Feng Y, et al. Exp Ther Med. 2014 Feb;7(2):423-428. doi: 10.3892/etm.2013.1439. Epub 2013 Dec 6. Exp Ther Med. 2014. PMID: 24396418 Free PMC article.
• Effects of lysophosphatidic acid on sling and clasp fibers of the human lower esophageal sphincter.
  Feng Y, Wei W, Chen L, Liu JF. Feng Y, et al. Turk Gogus Kalp Damar Cerrahisi Derg. 2022 Jul 29;30(3):404-409. doi: 10.5606/tgkdc.dergisi.2022.22084. eCollection 2022 Jul. Turk Gogus Kalp Damar Cerrahisi Derg. 2022. PMID: 36303683 Free PMC article.
• Lysophospholipid Mediators in Health and Disease.
  Kano K, Aoki J, Hla T. Kano K, et al. Annu Rev Pathol. 2022 Jan 24;17:459-483. doi: 10.1146/annurev-pathol-050420-025929. Epub 2021 Nov 23. Annu Rev Pathol. 2022. PMID: 34813354 Free PMC article. Review.

References

1. 1. Biochem J. 1967 Jan;102(1):221-9 - PubMed
2. 1. Biochem J. 1967 Jan;102(1):216-20 - PubMed
3. 1. J Pharmacol Exp Ther. 1968 Mar;160(1):1-10 - PubMed
4. 1. Pharmacol Rev. 1968 Mar;20(1):1-48 - PubMed
5. 1. Acta Physiol Scand. 1963 May;58:1-12 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal